In deliveryUnited Kingdom
OPDIVO (NIVOLUMAB) 600MG/5ML SOLUTION FOR INJECTION VIAL, 5 mL
- Published
- Published 24 June 2026
Overview
Belfast Health & Social Care Trust has awarded a contract for the supply of OPDIVO (Nivolumab) 600mg/5ml solution for injection vials to Bristol-Myers Squibb Pharmaceuticals Limited for £3.3 million. The contract is currently in delivery and complete status as of 23 June 2026.
Key details
- Country
- United Kingdom
- Status
- In delivery
- Procedure
- Direct
- Published
- 24 June 2026
Award outcome
- Awarded value
- £3,300,000
- Award date
- 23 June 2026
- Contract period
- 5 July 2026 → 30 June 2028
- BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract
7 July 2026
View notice ↗Contract
24 June 2026
View notice ↗Contract
24 June 2026
View notice ↗
Contracting authority
Belfast Health & Social Care Trust
BuyerBelfast, United Kingdom
GB-PPON: PLQJ-5727-JCLR
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.